Director Arun Sarin filed a Form 4 with the SEC on November 17, 2026, disclosing the acquisition of 10 Class A ordinary shares of Accenture plc on November 13, 2026, via a restricted share unit grant under anti-dilution provisions.

Key Highlights

  • Reporting person: Arun Sarin, listed as a Director of Accenture plc (NYSE:ACN)
  • Transaction date: November 13, 2026
  • Shares acquired: 10 Class A ordinary shares, acquired (Code A) at a price of $0
  • Reason for grant: Anti-dilution adjustment to previously granted RSU awards, reflecting Accenture plc's payment of a cash dividend
  • Beneficial ownership following transaction: 9,637 Class A ordinary shares held directly
  • Filing signed: By Danika Haueisen, Attorney-in-Fact for Arun Sarin, on November 17, 2026

Anti-Dilution RSU Adjustment Details for Director Arun Sarin

According to the filing, Arun Sarin, a Director at Accenture plc, received 10 Class A ordinary shares on November 13, 2026, through a grant of Restricted Share Units. The filing states that this grant was made "pursuant to the anti-dilution provisions of previously granted RSU awards, to reflect Accenture plc's payment of a cash dividend." The transaction is coded as an acquisition (Code A) with a stated price of $0.

Following this transaction, the filing reports that Sarin directly holds 9,637 Class A ordinary shares of Accenture plc. No derivative securities transactions were reported in Table II of the filing. The form was filed by one reporting person, and Sarin's address is listed as c/o Accenture, 500 W. Madison Street, Chicago, Illinois 60661.

The Form 4 was submitted by Danika Haueisen acting as Attorney-in-Fact for Arun Sarin. No amendment date is listed, indicating this is an original filing. The earliest transaction date noted in the filing is November 13, 2026.

What Was Disclosed

Arun Sarin, a Director at Accenture plc (NYSE:ACN), reported the acquisition of 10 Class A ordinary shares at $0 on November 13, 2026, as an anti-dilution RSU adjustment tied to a cash dividend. His direct beneficial ownership following the transaction totals 9,637 shares.